徐璐 - Shanghai Jiao Tong University College of Basic Medical Sciences

基本信息

浏览量：13

职业迁徙

个人简介

研究方向：肿瘤药理

研究兴趣

论文共 90 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis

Dailong Li, Chunzhen Zhang,Kui Yang, Zhiwei Ma, Lili Ma,Chunlai Cheng,Lu Xu, Sha Wan

Medicineno. 3 (2024): e36865-e36865

引用0浏览0WOS引用

GSTO1 Aggravates EGFR-TKIs Resistance and Tumor Metastasis Via Deglutathionylation of NPM1 in Lung Adenocarcinoma

Ning-xiang Shen,Ming-yu Luo,Wei-ming Gu,Miaomiao Gong,Hui-min Lei,Ling Bi, Cheng Wang, Mo-cong Zhang,Guanglei Zhuang,Lu Xu,Liang Zhu,Hong-zhuan Chen,Ying Shen

ONCOGENE (2024)

引用0浏览0WOSNATURE引用

A Phosphoglycerate Mutase 1 Allosteric Inhibitor Restrains TAM-mediated Colon Cancer Progression

Cheng Wang, Minghao Zhang, Shunyao Li,Miaomiao Gong,Ming-yu Luo, Mo-cong Zhang,Jing-Hua Zou,Ningxiang Shen,Lu Xu, Hui-min Lei, Ling Bi,Liang Zhu, Zhengting Wang,Hong-zhuan Chen,Lu Zhou,Ying Shen

Acta Pharmaceutica Sinica B (2024)

引用0浏览0引用

SCARB1-encoded Circ _0029343 Induces P73 Splicing to Promote Growth and Metastasis of Hepatocellular Carcinoma Via Mir-486-5p/srsf3 Axis

Shuo Zhu,Shengya Cao,Jinhui Che,Le Zhao,Zhan Su,Deqiang Li,Ruifeng Pei,Lu Xu,Yiren Ding,Wuyuan Zhou

Journal of biochemical and molecular toxicologyno. 2 (2024)

引用0浏览0WOS引用

Valproic Acid Increased the Efficacy of EGFR TKIs on EGFR/TP53 Co-Mutated Lung Cancers and Downregulated Mutant-P53 Levels

Mengdi Hu,Hanyue Cheng, Yijing Yang,Lu Xu

Molecular Carcinogenesisno. 2 (2023): 275-285

引用0浏览0WOS引用

Comparison of Clinicopathological Characteristics and Response to Neoadjuvant Systemic Therapy in Patients with HER2-low-positive and HER2-zero Breast Cancer

Wenjie Shi,Xinyu Wan,Jinzhi He,Ye Wang, Weiwei Zhang,Yinggang Xu,Xiaofeng Huang,Rui Chen,Lu Xu,Xiaoming Zha,Jue Wang

Journal of Investigative Medicine（2023）

引用0浏览0WOS引用

Data from Acquired Resistance to EGFR TKIs Mediated by TGFβ1/Integrin Β3 Signaling in EGFR-Mutant Lung Cancer

Caiyun Wang,Tao Wang,Dacheng Lv,Ling Li,Jinnan Yue,Hong-Zhuan Chen,Lu Xu

crossref（2023）

引用0浏览0引用

716 Phase 2 Study of the HER2-targeting TLR7/8 Immune Stimulating Antibody Conjugate (ISAC) BDC-1001 Monotherapy +/- Nivolumab in Patients with HER2+ Colorectal, Endometrial, or Gastroesophageal Cancer

Regular and Young Investigator Award Abstracts (2023)

引用0浏览0引用

A Phosphoglycerate Mutase 1 Allosteric Inhibitor Overcomes Drug Resistance to EGFR-targeted Therapy Via Disrupting IL-6/JAK2/STAT3 Signaling Pathway in Lung Adenocarcinoma

Qian Liang,Miaomiao Gong,Jing-Hua Zou,Ming-yu Luo,Lu-lu Jiang,Cheng Wang,Ning-xiang Shen, Mo-cong Zhang,Lu Xu,Hui-min Lei,Ke-Ren Zhang,Rui Zhang,Guanglei Zhuang,Liang Zhu,Hong-zhuan Chen,Lu Zhou,Ying Shen

Drug resistance updates（2023）

引用2浏览0WOS引用

丙戊酸协同顺铂抑制乳腺癌和结直肠癌细胞生长

成含月, 杨怡静, 张亚丽, 王涛, 李羚, 王彩云,徐璐

Progress in Modern Biomedicineno. 19 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Lu Xu(徐璐)

副研究员

论文共 90 篇作者统计合作学者相似作者